404LG Life Sciences, Released Zemimet, New Compositive Drug for Diabetic Treatment - NSP NEWS AGENCY(English)
Skip to main content Go body Go Menu
G03-8236672469

LG Life Sciences, Released 'Zemimet', New Compositive Drug for Diabetic Treatment

NSP NEWS AGENCY, By Hanah Choi Journalis, 2016-01-09 09:33 END7
#LG Life Siences

(Seoul=NSP News Agency) Hanah Choi Journalist = LG Life Sciences released 'Zemimet SR Tab', a new line-up of Zemimet which is a self-developed new drug complex for diabetic treatment.

Zemimet®SR is complex drug of Zemiglo and metformin SR Tab, a self-developed new drug for diabetic treatment of which blood glucose consolidation ability increased compared to existing single drug.

In addition, it is a product that minimized side effects in gastrointestinal system often caused with metformin by providing sustained release of drug into gastrointestinal tract taking through unique formulation technology of LG life sciences.

G03-8236672469

Particularly, size of Zemimet SR Tab was 50/500mg, reduced 20% compared to that of prior drug by means of crystallization technology which improved convenience of drug-taking.

NSP News Agency/NSP TV Hanah Choi Journalist, hana1914@nspna.com
Copyright ⓒ Korea's economic news agency NSP NEWS·NSP TV. All rights reserved-Redistribution Prohibited.